Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.07
Performance (%)
-1.29%
Price
16.03.26
€76.50
Summary
This prediction is currently active. With a performance of -1.29%, the BUY prediction for Rhythm Pharmaceuticals by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 17.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -1.29% |
| iShares Core DAX® | -0,68 % |
| iShares Nasdaq 100 | -0,03 % |
| iShares Nikkei 225® | -0,54 % |
| iShares S&P 500 | -0,21 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Royal Bank Of Canada from $140.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€84.50
18.02.26
18.02.26
-
18.02.27
18.02.27
-9.47%
16.03.26
16.03.26
